Table 1.
Clinical characteristics of the patients.
| Total patients (n = 484) | Nondiabetic patients (n = 212) | Diabetic patients (n = 272) | p value | |
|---|---|---|---|---|
| Age, mean ± SD, years | 67.9 ± 13.7 | 65.9 ± 15.3 | 69.5 ± 12.2 | 0.004* |
| Male sex, n (%) | 315 (65.1%) | 145 (68.4%) | 170 (62.5%) | 0.177 |
| Comorbidities, n (%) | ||||
| Hypertension | 346 (71.5%) | 132 (62.3%) | 214 (78.7%) | <0.001* |
| Diabetes | 272 (56.2%) | 0 (0%) | 212 (100%) | N.A. |
| Hyperlipidemia | 147 (30.4%) | 62 (29.2%) | 85 (31.2%) | 0.635 |
| Atrial fibrillation | 74 (15.3%) | 38 (17.9%) | 36 (13.2%) | 0.155 |
| NIHSS at admission, median (IQR) | 4 (2–8) | 4 (2–8) | 4 (2–7) | 0.972 |
| mRS at 3 months, median (IQR) | 1 (1–2) | 1 (1–2) | 1 (1–3) | 0.654 |
| Poor neurological outcome, n (%) | 118 (24.4%) | 48 (22.6%) | 70 (25.7%) | 0.432 |
| Stroke etiology subtypes, n (%) | 0.658 | |||
| Large artery atherosclerosis | 133 (27.5%) | 56 (26.4%) | 77 (28.3%) | |
| Small artery occlusion | 166 (34.3%) | 69 (32.5%) | 97 (35.7%) | |
| Cardioembolism | 26 (5.4%) | 12 (5.7%) | 14 (5.1%) | |
| Other determined etiology | 1 (0.2%) | 1 (0.5%) | 0 (0%) | |
| Undermined etiology | 158 (32.6%) | 74 (34.9%) | 84 (30.9%) | |
| Admission random glucose, mean ± SD, mg/dL | 175.5 ± 86.8 | 129.5 ± 34.8 | 211.4 ± 97.6 | <0.001* |
| Fasting glucose, mean ± SD, mg/dL | 132.9 ± 58.7 | 102.1 ± 19.9 | 156.9 ± 67.3 | <0.001* |
| HbA1c, mean ± SD, % | 7.0 ± 1.8 | 5.8 ± 0.4 | 8.0 ± 1.8 | < 0.001* |
Notes.
*
p < 0.05.
- IQR
- interquartile range
- SD
- standard deviation